Iron oxide (Fe3O4) containing magnetic chitosan nanoparticles were prepared with Concanavalin-A and Bleomycin as multifunctional nanocarriers for the targeted cancer therapy by co-precipitation techniques. The chemical structures of nanoparticles were analyzed by FTIR and the magnetic properties of the nanoparticles were evaluated by electron spin resonance technique and vibrational scanning mangnetometer measurements. The in vitro release profiles of Bleomycin were investigated and chitosan nanoparticles characteristics were optimized for subsequent in vivo applications. The magnetic chitosan nanoparticles are biocompatible-based MTT assays. The therapeutic potential of these nanoparticles are being investigated for in vivo applications.
Stewart, B.W. and Kleihues, P. (eds) (2003). World Cancer Report, Lyon: IARC Press.
2.
Alison, M.R. ( 2003). The Cancer Handbook, London: Nature Publishing Group.
3.
Bertino, J. ( 2002). Four-Volume Set, 1-4, London: Academic Press.
4.
Catane, R., Cherny, N.I., Kloke, M., Tanneberger, S. and Schrijvers, D. ( 2006). Handbook of Advanced Cancer Care, Oxford: Taylor & Francis.
5.
Gabriel, J. ( 2007). The Biology of Cancer, New York: John Wiley & Sons.
6.
Llombart, A., Felipo, V. and Lopez-Guerrero, J.A. (eds) (2006). New Trends in Cancer for the 21st Century, New York: Springer.
7.
Jain, R.K. ( 2001). Delivery of Molecular and Cellular Medicine to Solid Tumors, Advanced Drug Delivery Reviews, 46: 149-168.
8.
Parmiani, G., Castelli, C., Dalerba, P., Mortarini, R., Rivoltini, L., Marincola, F.M. et al. (2002). Cancer Immunotherapy with Peptide-based Vaccines: What have We Achieved? - Where are We Going?, Journal of the National Cancer Institute, 94: 805-818.
9.
Jang, S.H., Wientjes, M.G., Lu, D. and Au, J.L.S. ( 2003). Drug Delivery and Transport to Solid Tumors, Pharmaceutical Research, 20: 1337-1350.
10.
Guowei, D., Adriane, K., Chen, X.Z., Jie, C. and Yinfeng, L. ( 2007). PVP Magnetic Nanospheres: Biocompatibility, In Vitro and In Vivo Bleomycin Release, International Journal of Pharmaceutics, 328: 78-85.
11.
Bentzen, S.M. (2005). Theragnostic Imaging for Radiation Oncology: Dose-painting by Numbers, Lancet Oncol , 6: 112-117.
12.
Neuberger, T. , Schöpf, B., Hofmann, H., Hofmann, M. and von Rechenberg , B. (2005). Superparamagnetic Nanoparticles for Biomedical Applications: Possibilities and Limitations of a New Drug Delivery System, Journal of Magnetism and Magnetic Materials, 293: 483-496.
13.
Jordan, A., Wust, P.Scholz, R., Faehling, H., Krause, J. and Felix, R. ( 1997). Magnetic Fluid Hyperthermia, In: Haneli, U., Schütt, W., Teller, J. and Zborowski, M. (eds), Scientific and Clinical Applications of Magnetic Carriers, p. 569, New York: Plenum Press.
14.
Kim, D.H. , Lee, S.H., Im, K.H., Kim, K.N., Kim, K.M., Shim, I.B. et al. (2006). Surface-modified Magnetite Nanoparticles for Hyperthermia: Preparation, Characterization, and Cytotoxicity Studies, Current Applied Physics, 6S1: e242-e246.
15.
Gupta, A.K. and Gupta, M. (2005). Synthesis and Surface Engineering of Iron Oxide Nanoparticles for Biomedical Applications, Biomaterials, 26: 3995-4021.
16.
Denkbaş, E.B. and Ottenbrite , R.M. (2006). Perspectives on: Chitosan Drug Delivery Systems: Based on their Geometries , Journal of Bioactive and Compatible Polymers, 21: 351-368.
17.
Rinaudo, M. (2006). Chitin and Chitosan: Properties and Applications, Progress in Polymer Science, 31: 603-632.
18.
Majeti, N.V. and Kumar, R. (2000). A Review of Chitin and Chitosan Applications, Reactive & Functional Polymers , 46: 1-27.
19.
Dang, J.M. and Leong, K.W. ( 2006). Natural Polymers for Gene Delivery and Tissue Engineering , Advanced Drug Delivery Reviews, 58: 487-499.
20.
Rozema, D.B. and Lewis, D.L. (2003). siRNA Delivery Technologies for Mammalian Systems, Targets, 2: 253-260.
21.
Aigner, A. ( 2006). Gene Silencing Through RNA İnterference (RNAi) İn Vivo: Strategies Based on the Direct Application of siRNAs, Journal of Biotechnology, 124: 12-25.
22.
Katas, H. and Alpar, H.O. ( 2006). Development and Characterisation of Chitosan Nanoparticles for siRNA Delivery, Journal of Controlled Release, 115: 216-225.
23.
Ozturk, E. ( 2007). Preparation and Characterization of Biochemically Modified Polymeric Carriers for Cancer Therapy, Thesis, Hacettepe University.
24.
Sood, A.K., Mangala, L.S., Han, H., Lu, C., Ali-Fehmi, R., Stone, R. et al. (2009). In Vivo Angiogenic Gene Silencing Using Chitosan Nanoparticles in Ovarian Carcinoma, Gynecologic Oncology, 112: 136-137.
25.
Marques, M.P.M. , Girao, T., De Lima, M.C.P., Gameiro, A., Pereira, E. and Garcia, P. (2002). Cytotoxic Effects of Metal Complexes of Biogenic Polyamines. I. Platinum (II) Spermidine Compounds: Prediction of their Antitumor Activity, Biochimica et Biophysica Acta, 1589: 63-70.
26.
Demirbilek, M. and Pişkin , E. (2008). Effects of Copper-Cyclam and Copper-Cyclam/Polymer Complexes on HeLa Cells , Hacettepe Journal of Biology & Chemistry, 36: 263-271.
27.
Bangs Laboratories (2002). Technotes 205, Rev003, pp. 1-8.
28.
Zhu, Y. and Wu, Q. (1999). Synthesis of Magnetite Nanoparticles by Precipitation with Forced Mixing, Journal of Nanoparticle Research, 1: 393-396.
29.
Pardoe, H., Chua-Anusorn, W., St Pierre,. T.G. and Dobson, J. ( 2001). Structural and Magnetic Properties of Nanoscale Iron Oxide Particles Synthesized in the Presence of Dextran or Polyvinyl Alcohol , Journal of Magnetism and Magnetical Materials, 225: 41-46.
30.
Denkbaş, E.B. and Odabaşı , M. (2000). Chitosan Microspheres and Sponge: Preparation and Characterization, Journal of Applied Polymer Science, 76: 1673-1643.
31.
Yamaura, M. , Camilo, R.L., Sampao, L.C., Macedo, M.A., Nakamura, M. and Toma, H.E. (2004). Preparation and Characterization of (3-Aminopropyl)Triethoxysilane-Coated Magnetite Nanoparticles, Journal of Magnetism and Magnetical Materials, 279: 210-217.
32.
Sayar, F., Güven, G. and Pişkin, E. ( 2006). Magnetically Loaded Poly(Methyl Methacrylate-Co-Acrylic Acid) Nano-particles, Colloidal Polymer Science, 284: 965-978.
33.
Li, G., Jiang, Y., Huang, K.L., Ding, P. and Chen, J. ( 2008). Preparatıon and Propertıes of Magnetıc Fe3O4-Chıtosan Nanopartıcles, Journal of Alloys and Compounds, 466: 451-456.
34.
Delfini, C. , Amici, C., Belardelli, F., Oberholtzer, G. and Sorrentino, M. (1982). Concanavalin A-induced İnhibition of Abrin and Ricin Activity Parallels with a Decrease of the Number of Toxin-binding Uptake-elution Cycles, Experimental Cell Research, 142: 427-435.
